LexDanaLexDanabeta
Inventor

Scott K. Thompson

Inventor
Phoenixville, PA, US

Overview

36→
Patents
1997–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds9%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
C12NMicroorganisms or enzymes3%
Y02ATechnologies for adaptation to climate change2%
C07BGeneral methods of organic chemistry1%
C07KPeptides1%
PatentTitleYear
D0926238Drill press202110,869,872Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways202010,751,332Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer202010,611,768P2X202010,590,127P2X202010,544,145P2X202010,471,051Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer201910,316,039P2X201910,294,212Inhibitors of the kynurenine pathway201910,226,468Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways201910,174,039P2X20199,944,637P2X20189,908,879'P2X3 and/or P2X2/3 compounds and methods'20189,896,445'Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer'20189,815,811'Inhibitors of the kynurenine pathway'20179,757,382'Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways'20179,499,495'Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways'20169,199,975'Biaryl imidazole derivatives for regulating CYP17'20159,180,115'Cyclohexylamines'20159,115,092'Substituted quinazoline and pyrido-pyrimidine derivatives'20158,865,741'Aminoindane compounds and use thereof in treating pain'20148,685,418'Cyclohexylamines'20148,440,662'Substituted quinazoline and pyrido-pyrimidine derivatives'20137,563,784'Protease inhibitors'20097,560,586'Acid and ester compounds and methods of using the same'20097,405,209'Protease inhibitors'20087,365,085'Compounds and methods'20087,323,494'Compounds and methods'20087,304,082'1,2,4-triazole derivatives, compositions, process of making and methods of use'20077,247,748'Amide compounds and methods of using the same'20076,331,542'Protease inhibitors'20016,284,777'Carbohydrazide protease inhibitors'20016,232,342'Protease inhibitors'20015,998,470'Protease inhibitors'19995,955,492'Carboxylic acid indole inhibitors of chemokines'19995,684,032'Compounds'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2009Patents assigned to SMITHKLINE BEECHAM CORP (12)· patent assignee history
1997–2020Based in Phoenixville, PA, US· patent location history
2007–2009Based in King of Prussia, PA, US· patent location history
2013–2014Patents assigned to ENDO PHARMACEUTICALS INC (2)· patent assignee history
2014–2020Patents assigned to ASANA BIOSCIENCES LLC (17)· patent assignee history
2017–2019Patents assigned to CURADEV PHARMA PRIVATE LTD (2)· patent assignee history
2017–2019Patents assigned to CURADEV PHARMA PVT LTD (2)· patent assignee history
2021Based in Newcastle upon Tyne, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASANA BIOSCIENCES LLC172014–2020
SMITHKLINE BEECHAM CORP121997–2009
CURADEV PHARMA PRIVATE LTD22017–2019
CURADEV PHARMA PVT LTD22017–2019
ENDO PHARMACEUTICALS INC22013–2014
Locations
LocationPatentsSpan
Phoenixville, Pennsylvania, US301997–2020
King of Prussia, Pennsylvania, US52007–2009
Newcastle upon Tyne, GB12021